It's likely NOT 'orange man bad' but something even more sinister.
Doctor exposes the REAL reason why the media, left HATE hydroxychloroquine to treat COVID-19 82,363 views Jul 30, 2020 Glenn Beck
If your only source was the mainstream media, you might think hydroxychloroquine is an extremely dangerous drug. But ER Doctor Simone Gold speaks to Glenn, and she sets the record straight: not only is it a noncontroversial drug that's commonly used around the world, but it could even be bought over the counter in some countries (like France). So why, then, did that all change when President Trump spoke about its potential use in the fight against COVID-19? Why did France remove it from its shelves? And WHY did the media begin praising another drug -- Remdesivir -- when early trials didn't show immense promise? Gold answers all these questions, and more.
August 6, 2020 Hydroxychloroquine Is Not about Trump
I’m sure you are aware of the politics surrounding the “Trump drug,” as opinions about the use of hydroxychloroquine (HCQ) in COVID-19 seem to correlate with support or opposition to President Trump. But that’s not the main story, as Dr. Simone Gold pointed out in a Facebook-censored interview with Glenn Beck.
President Trump mentioned HCQ as a potential “game changer” on Mar 21. But the war against HCQ was already on. Until Jan 15, 2020, HCQ was available over the counter in France. After that it became available by prescription only, days before the first Western reports on the epidemic, which had been circulating in Wuhan, China, at least since October 2019. This was part of a multinational effort to restrict HCQ.
Interesting timing: The drug sold as Plaquénil—translating to “plague nil or no plague”—was restricted in the West just before the plague was acknowledged.
The potential value of HCQ has been known since 2005, when the journal Virology published an article entitled “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.” Chloroquine, which works like its derivative HCQ, inhibited viral spread when cells were treated either before or after exposure to SARS-CoV-1, a close relative of SARS-CoV-2, the cause of COVID-19.
Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Disease (NIAID), should certainly be aware of this work. And since NIAID had partially funded research on the virus at the Wuhan Institute of Virology, Fauci was in a position to know a lot.
The sometimes-masked face of “Science” in the federal response to COVID-19, Fauci is one of the main obstacles to the freedom to prescribe HCQ. He demands randomized controlled trials for HCQ, yet he has called not-yet-approved remdesvir the “standard of care,” despite limited evidence.
The unprecedented worldwide war on a long-established drug, with fronts in many nations and a coordinated media censorship effort, calls for contact tracing. What are the political and financial relationships of all the decisionmakers in CDC, WHO, FDA, pharmaceutical companies, medical journals, media, social media, academic centers, foundations, and political parties (here and abroad)?
For information on the “natural experiment” of early use vs. nonuse of HCQ—a 79% difference in mortality—see hcqtrial.com.